High THY1 expression was reported to relate with aggressive clinicopathological features of GC cases (Numakura et al., 2019), and the silencing of which would inhibit the malignant traits and enhance apoptosis of GC cells (Wu et al., 2019). This evidence concerns the gene THY1 and gastric cancer.